OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
87
Results
Show all
Save search
Copy query
Show results for
Unknown
(87)
Publication Date
Release Date
2022
(20)
2021
(14)
2023
(12)
2024
(10)
2025
(8)
2020
(6)
2019
(3)
2018
(3)
2012
(3)
2017
(2)
2015
(2)
2014
(2)
2026
(1)
2009
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
Redefining genera of cereal pathogens:
Oculimacula
,
Rhynchosporium
and
Spermospora
.
Not available
S-EPMC8165968
|
biostudies-literature
Cite
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Not available
S-EPMC7666431
|
biostudies-literature
Cite
Bipyridine complexes of E
3+
(E = P, As, Sb, Bi): strong Lewis acids, sources of E(OTf)
3
and synthons for E
I
and E
V
cations.
Not available
S-EPMC6054056
|
biostudies-literature
Cite
Defining timeliness in care for patients with lung cancer: protocol for a scoping review.
Not available
S-EPMC7643508
|
biostudies-literature
Cite
Defining timeliness in care for patients with lung cancer: a scoping review.
Not available
S-EPMC8990712
|
biostudies-literature
Cite
Key priorities to prevent avoidable asthma hospitalisations: insights from end-users
Not available
S-EPMC12926825
|
biostudies-literature
Cite
Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma.
Not available
S-EPMC6682217
|
biostudies-literature
Cite
Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery.
Not available
S-EPMC8963579
|
biostudies-literature
Cite
Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.
Not available
S-EPMC6971867
|
biostudies-literature
Cite
Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.
Not available
S-EPMC7712927
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets